These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6976792)

  • 21. Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma.
    Kataoka Y; Matsumura T; Yamamoto S; Sugimoto T; Sawada T
    Cancer Lett; 1993 Sep; 73(1):11-21. PubMed ID: 8402593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
    Shanahan F; Brogan MD; Newman W; Targan SR
    J Immunol; 1986 Jul; 137(2):723-6. PubMed ID: 3487579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Mizutani Y; Yoshida O; Miki T
    J Urol; 1999 Dec; 162(6):2170-5. PubMed ID: 10569614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells.
    Hutchinson GH; Heinemann D; Symes MO; Williamson RC
    Br J Cancer; 1981 Sep; 44(3):396-402. PubMed ID: 7284236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
    Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
    J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
    Matera L; Foa R; Moore M
    J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
    Watanabe Y; Hashizume Y; Shimizu J; Yoshida M; Watanabe S; Iwa T; Sakai S; Migita S; Sato H; Murayama T
    Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
    Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
    Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
    Xu ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):345-7. PubMed ID: 2177396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.
    Kim TY; von Eschenbach AC; Filaccio MD; Hayakawa K; Parkinson DR; Balch CM; Itoh K
    Cancer Res; 1990 Sep; 50(17):5263-8. PubMed ID: 2143685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
    Vose BM; Vánky F; Klein E
    Int J Cancer; 1977 Dec; 20(6):895-902. PubMed ID: 591128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes.
    Vose BM; Vánky F; Argov S; Klein E
    Eur J Immunol; 1977 Nov; 7(11):353-7. PubMed ID: 304003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
    Zarling JM; Bach FH; Kung PC
    J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of autologous-tumor specific cytotoxic T cells induced by means of butanol-extracted soluble antigen from T lymphocytes in colon cancer patients].
    Hamagashira K
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):128-37. PubMed ID: 8464410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.